Device Trial Radar · NCT07246980
Continuous Observational Monitoring Program for Allay™ Hydrogel Cap Safety and Success Study
Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
May 6, 2026
Primary completion
Jan 1, 2029
Study completion May 1, 2029
Sponsor
- Lead sponsor
- Tulavi Therapeutics,Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 24, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
is is a multi-center, open-label, observational registry study (both prospective and retrospective) designed to evaluate the safety and performance of the allay™ Hydrogel Cap. This cap is an in situ forming implantable hydrogel medical device used in various peripheral nerve surgeries, including amputation and neuroma excision. The study aims to gather demographic, operative, and clinical outcomes data from patients who have received the device. The primary endpoints focus on the device's clinical performance, assessed using patient-reported outcomes (PROs). These include tracking changes in pain scores, pain intolerance, and cold intolerance, as well as the incidence of neuroma recurrence and changes in pain medication use from baseline. Secondary endpoints concentrate on safety, monitoring the incidence of device failures, surgical complications, unplanned re-operations, and unexpected adverse device events (UADEs) within the study population. Essentially, the registry is collecting real-world data to determine how well and how safely the allay™ cap performs in a clinical setting.
Conditions
- Peripheral Nerve Injuries
Interventions
Nerve CapDevice
Patients who have or will receive allay Hydrogel Cap
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of change in Pain Scores from baseline using VASTime frame: Baseline (Pre Surgery ), 2 Weeks, 1 month, 4 month, 12 month and 24 month (Post Surgery)
- Assessment of change in Pain scores from baseline using Numerical Rating ScaleTime frame: Baseline (Pre Surgery ), 2 Weeks, 1 month, 4 month, 12 month and 24 month (Post Surgery)
- Assessment of change in Pain Interference from baseline using PROMIS PI Short Form 5bTime frame: Baseline (Pre Surgery ), 2 Weeks, 1 month, 4 month, 12 month and 24 month (Post Surgery)
3 more outcomes with a free account
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Kaiser Permanente
Redwood City, California · Recruiting
University of Colorado Anschutz.
Englewood, Colorado · Recruiting
Orlando Health
Orlando, Florida · Recruiting
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.